A protein measured in a routine blood sample may reveal who will develop cognitive impairment, years before memory begins to fail.
Imagine a sixty-eight-year-old who forgets nothing. She remembers birthdays, bus routes, the name of every grandchild's teacher. Yet a vial of her blood might already be hinting at a future she cannot feel. Could that be true?
A large international study suggests it could. Led by the Mass General Brigham Neuroscience Institute, researchers pooled data from six studies and trials in North America, Japan and Australia. Together they followed 2,684 older adults who showed no cognitive impairment at the start. Each person gave a blood sample, which was analysed for a protein called phosphorylated tau 217, or p-tau217.
Each also had a PET brain scan, and annual check-ups tracked memory and thinking. Some participants joined as early as 2004; the latest follow-ups took place in 2025. The pattern was striking. About 478 people eventually developed impairment, and higher p-tau217 levels at the start were strongly linked to that outcome.